1
2020.
Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis
Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više